Attached files
file | filename |
---|---|
8-K - FORM 8-K - Zep Inc. | d8k.htm |
![]() Acquisition of Amrep, Inc. January 6, 2010 Exhibit 99.1 |
![]() Cautionary and Forward-Looking Statements Copyright 2010. Zep Inc. - All rights reserved. 2 In connection with the acquisition of Amrep, Inc., Zep Inc. has performed due diligence procedures on and
reviewed the financial results of Amrep, Inc. contained within this presentation and other
related oral and written releases of information. The financial results of Amrep, Inc.
discussed herein represent results of Amrep, Inc. for the twelve month period beginning December 1, 2008 and ended November 30, 2009. Amrep, Inc. has operated as a privately held company with no interim audit
or review requirements. Moreover, Amrep, Inc. has a December 31 fiscal year end; therefore, the
financial results of Amrep, Inc. discussed herein and in other oral and written releases of
information have been subjected to neither audit nor review procedures conducted by an independent audit firm, and pre-acquisition due diligence procedures must not be considered a
substitute for such. Because substantially all of the twelve month period reflected in the
results presented herein has been neither audited by nor subject to the review of an independent
audit firm, the financial results presented herein are preliminary and subject to adjustment. Therefore, this financial information should be considered preliminary as actual historical financial results of Amrep,
Inc. could differ materially from these disclosures. Zep Inc. intends to file the
financial statements of Amrep, Inc. required by Regulation S-X and Form 8-K as they become available for filing with the Securities and Exchange Commission. These financial statements will
not include a trailing twelve month period ended November 30, 2009. This presentation also contains forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to
certain risks and uncertainties that could cause actual results, expectations, or outcomes to
differ materially from the historical experience of Amrep, Inc. as well as Zep Inc.s present expectations or projections. All statements other than statements of historical fact could be deemed forward-looking, including, but
not limited to, any projections of financial information; any statements about historical
results that may suggest trends; any statements of the plans, strategies, synergies, and
objectives of management for future operations; any statements of expectation or belief regarding future events, potential markets or market size, technology developments, or enforceability of intellectual property
rights; and any statements of assumptions underlying any of the items mentioned.
The statements contained herein or implied hereby are based on unaudited estimates not yet formally
reviewed by accountants and information available to us at the time of this presentation and
are not guarantees of future performance. Actual results could differ materially from our
current expectations as a result of many factors, including but not limited to: underlying assumptions or expectations related to customer and supplier relationships and prices; competition; ability to realize
anticipated benefits from the acquisition and other initiatives and the timing of benefits to
be derived therefrom; market demand; litigation and other contingent liabilities, such as
environmental matters; and economic, political, governmental, technological, and natural disaster related factors affecting the operations of Zep Inc. and/or Amrep, Inc., tax rate, markets, products, services, and prices,
among others. For a description of additional risks and uncertainties that could affect these
statements, please refer to Zep Inc.s filings with the Securities and Exchange Commission,
including its fiscal year 2009 Annual Report on Form 10K. The discussion under the heading Risk Factors in Part I, Item 1A of Zeps fiscal year 2009 Form 10-K is specifically incorporated
by reference into this presentation. We assume no obligation and do not intend to update
these forward-looking statements. |
![]() 3 Key Markets: Specialty Chemical Products: Adhesives Air Care Automotive Maintenance Cleaners Degreasers Disinfectants Floor Care Greases Herbicides Insecticides Oils Manufacturing Facilities: Georgia Texas Employees: Approximately 200 Industry-Leading Brands Amrep Overview Copyright 2010. Zep Inc. - All rights reserved. 1 Please see appendix for reconciliation of Net Income, which totaled $0.7 million during the twelve months ended November 30, 2009, to Adjusted EBITDA. Twelve months ended November 30, 2009 Sales $106.1 million Adjusted EBITDA $9.9 million (Based on Preliminary and Unaudited Results) 1 |
![]() 4 Strategic Fit Immediately provides a strong presence in automotive market Increases penetration in distribution channel Expands product portfolio with nationally recognized brands Compliments existing customer base Adds additional flexible aerosol manufacturing capabilities Delivers significant private label capabilities and relationships Existing strong management team will continue to run Amreps operations Benefits to Zep. . . Copyright 2010. Zep Inc. - All rights reserved. |
![]() 5 Market Opportunity Copyright 2010. Zep Inc. - All rights reserved. Distribution $7.3 45% Direct to Consumer $3.2 20% Retail $5.8 35% Est. $16B US Market (pre-acquisition) Distribution $7.3 38% Direct to Consumer $3.2 17% Retail $5.8 30% Est. $19B US Market (post-acquisition) Automotive $2.8 15% US Cleaning Maintenance Chemicals Market in which Zep Inc.
Competes ($ billions) Automotive opportunity increases the available market for Zep Inc. from an estimated $16.3B to $19.1B 1 Source: Information compiled by Zep Inc. based on research provided by Kline & Company and the Automotive Aftermarket Industry Association. 1 1 |
![]() 6 Market Overview Go-to-Market Channel Distribution Retail Automotive OEM Estimated U.S. Market Size $7.3 Billion $5.8 Billion $2.8 Billion Brands Private Brand relationships Next Dimension brand Original Bike Works® brand Maintenance Chemicals Appearance Chemicals Functional Fluids Paint, Body, and Equipment Misty® brand increases access to JanSan Distribution markets I-Chem® brand increases access to MRO Distribution markets Minimal channel overlap with established Zep Inc. brands / customers Adds access to consumers through Advance Auto Parts and Auto Zone private brand relationships Adds the Next Dimension and Original Bike Works® brands to retail auto channel Current relationship with Automotive OEM customers provide access for additional Zep Inc. capability Key Market Access Enhancements Copyright 2010. Zep Inc. - All rights reserved. 1 Source: Information compiled by Zep Inc. based on research provided by Kline & Company and the Automotive Aftermarket Industry Association. 1 TM TM |
![]() 7 Amrep Revenue Breakdown for Twelve Months ended 11/30/09 Automotive 67% Jan San 16% MRO 9% Other 8% Distribution Channels . . . Top Customers Toyota Nissan Subaru Kia Corporate Express Sears AutoZone Advance Auto Lagasse Fastenal Triple S AmSan Private Label 80% Amrep Branded 20% Product Mix . . . Copyright 2010. Zep Inc. - All rights reserved. 1 Based on preliminary and unaudited financial results. 1 |
![]() Expands access to Jan San, MRO, and Automotive (OEM and retail aftermarket) distribution channels
Enhanced brand portfolio provides new marketing opportunities Cross-selling opportunities for existing product portfolio 8 Synergies Operational and Supply Chain Synergies . . . Revenue Synergies . . . Increased productivity resulting from Amreps Aerosol manufacturing capabilities and Zep Inc.s liquids / powders manufacturing capabilities Common supplier base Increased economies of scale (raw materials and logistics) Copyright 2010. Zep Inc. - All rights reserved. Administrative Synergies . . . Leverage back office functions |
![]() 9 Financing Overview Cash purchase price: $64.4 million Financed with 100% debt; utilizing existing debt capacity (Revolving Credit Facility and Receivables Facility) Zep has approximately $40 million of debt capacity post-acquisition (as of 11/30/09) Zep Inc. total debt/credit agreement adjusted EBITDA (1) (as of 11/30/09) : Pre-acquisition - < 0.9x Post-acquisition - < 2.3x Copyright 2010. Zep Inc. - All rights reserved. 1 As defined in Zep Inc.s credit agreement, which states that adjusted EBITDA is equal to EBITDA plus certain non-cash items. See appendices for further discussion.
|
![]() 10 Looking Ahead Amreps existing management team will continue to lead Amreps business with ability to leverage Zep Inc.s shared services platform Operational Outlook Financial Outlook Copyright 2010. Zep Inc. - All rights reserved. Deal is EPS accretive immediately, excluding transaction costs, opening Amrep balance sheet adjustments and restructuring costs Estimated annualized cost savings of $3-4 million expected as we enter F11 and up to $7 million
within 24 months Restructuring charges expected to be incurred as Zep implements integration plan beginning in Q2 of FY2010 |
![]() 11 Questions Copyright 2010. Zep Inc. - All rights reserved. |
![]() Appendices |
![]() 13 Amrep, Inc. Preliminary and Unaudited Adjusted EBITDA Reconciliation Copyright 2010. Zep Inc. - All rights reserved. ($ millions) Twelve Months Ended 11/30/09 Net Income $0.7 Interest Expense, net 2.4 Provisions for Income Taxes 0.4 Depreciation and Amortization 2.0 EBITDA $5.5 Environmental charges 4.4 Adjusted EBITDA $9.9 |
![]() Non-GAAP Disclosures This presentation includes the following supplemental non-GAAP financial measures of
Amrep, Inc.: EBITDA and adjusted EBITDA. GAAP means generally accepted
accounting principles in the United States. This presentation contains
reconciliations of each of these non-GAAP financial measures to the most
directly comparable GAAP financial measure, net income. EBITDA is equal to net income plus (a) interest expense, net; (b) provision for income taxes; and (c) depreciation and amortization. In this presentation, adjusted EBITDA is calculated by
adding to EBITDA certain charges recorded during December 2008 in
recognition of estimated environmental remediation costs associated with
efforts currently underway at one of Amrep, Inc.s owned manufacturing
facilities. We believe EBITDA and adjusted EBITDA and the ratios derived from these measures are
useful to an investor in evaluating the performance of Amrep, Inc. We
believe these measures adjust for items which we understand are generally
not indicative of Amrep, Inc.s core operating performance, and therefore should serve to enhance period-to-period comparability of operations
and financial performance. We also believe that analysts and investors
utilize EBITDA and adjusted EBITDA as supplemental measures to evaluate the
overall operating performance of companies in our industry. Managements use for these measure is not unlike those in the investment
community. EBITDA and adjusted EBITDA, and the ratios derived from these measures, as calculated by
us are not necessarily comparable to similarly titled measures used by other
companies. In addition, these measures: (a) do not represent net income or cash flows from operating activities as defined by
GAAP; (b) are not necessarily indicative of cash available to fund our cash flow needs; and (c) should not be considered in isolation of, as alternatives to, or more meaningful measures than
operating profit, net income, cash provided by operating activities, or our
other financial information as determined under GAAP. Copyright 2010. Zep Inc. - All rights reserved. 14 |
![]() Debt Covenant Disclosure Pre- and post-acquisition maximum leverage ratio computations are provided on the
Financing Overview slide of this presentation. The maximum leverage ratio is a restrictive debt
covenant associated with Zep Inc.s Revolving Credit Facility (the
credit agreement), which is the Companys primary borrowing
facility. This credit agreement allows for a maximum leverage ratio of 3.25. Failure to comply with this debt covenant represents an event of default under this credit agreement. Copyright 2010. Zep Inc. - All rights reserved. 15 |